Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Do Clinicians Prefer CBD Over THC For Mood Disorder Treatment? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The question of clinicians CBD preference is highly relevant as cannabis-based treatments move closer to psychiatric care. For patients with mood disorders , CBD is often viewed as safer and more stable than THC, making it the cannabinoid of choice for many professionals. Those managing a mental health condition such as depression or anxiety may benefit from CBD’s calming effects without the psychoactive risks associated with THC. 

Evidence points to CBD being better tolerated, though clinicians stress that more robust clinical trials are still needed to confirm its effectiveness. 

Can I use Medical Cannabis for Pain Relief?

Clinician Attitudes Towards Cannabinoids 

Examining clinicians’ CBD preference involves looking at how professionals compare CBD and THC in therapeutic practice. These perspectives help shape prescribing patterns and patient guidance. 

CBD Vs THC In Clinician Views 

When considering CBD vs THC in clinician views, most practitioners lean towards CBD due to its non-intoxicating nature, reduced side effect profile, and potential antidepressant-like mechanisms. 

Clinician Preference of Cannabinoids 

The clinician preference of cannabinoids often reflects concerns about THC’s risks, including anxiety, paranoia, or mood destabilisation, particularly in sensitive patients. 

CBD For Mood Clinicians 

Support for CBD for mood clinicians highlights its promise in reducing anxiety, improving sleep, and supporting emotional regulation, though most recommend it as an adjunct rather than a replacement for established therapies. 

In summary, the evidence suggests a clear clinician CBD preference in treating mood disorders, though cautious optimism remains the prevailing stance until more large-scale studies are available. 

For patients exploring CBD as part of mood care, providers like LeafEase can offer tailored consultations to support safe and evidence-informed use. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories